NO972522L - Monoklonale antistoffer med immunoundertrykkende aktivitet - Google Patents

Monoklonale antistoffer med immunoundertrykkende aktivitet

Info

Publication number
NO972522L
NO972522L NO972522A NO972522A NO972522L NO 972522 L NO972522 L NO 972522L NO 972522 A NO972522 A NO 972522A NO 972522 A NO972522 A NO 972522A NO 972522 L NO972522 L NO 972522L
Authority
NO
Norway
Prior art keywords
fragments
mab
monoclonal antibodies
fab
immunosuppressive activity
Prior art date
Application number
NO972522A
Other languages
English (en)
Norwegian (no)
Other versions
NO972522D0 (no
Inventor
Zoltan Nagy
Damir Vidovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO972522D0 publication Critical patent/NO972522D0/no
Publication of NO972522L publication Critical patent/NO972522L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO972522A 1994-12-07 1997-06-03 Monoklonale antistoffer med immunoundertrykkende aktivitet NO972522L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07
PCT/EP1995/004648 WO1996017874A1 (fr) 1994-12-07 1995-11-25 Fragments d'anticorps monoclonaux possedant une activite immunodepressive

Publications (2)

Publication Number Publication Date
NO972522D0 NO972522D0 (no) 1997-06-03
NO972522L true NO972522L (no) 1997-08-06

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972522A NO972522L (no) 1994-12-07 1997-06-03 Monoklonale antistoffer med immunoundertrykkende aktivitet

Country Status (19)

Country Link
EP (1) EP0787151A1 (fr)
JP (1) JP2001506122A (fr)
CN (1) CN1168679A (fr)
AR (1) AR002005A1 (fr)
AU (1) AU4256096A (fr)
BR (1) BR9509902A (fr)
CA (1) CA2206471A1 (fr)
CO (1) CO4480041A1 (fr)
CZ (1) CZ172497A3 (fr)
FI (1) FI972430L (fr)
HU (1) HUT77342A (fr)
IL (1) IL116228A0 (fr)
MA (1) MA23739A1 (fr)
NO (1) NO972522L (fr)
PE (1) PE52996A1 (fr)
PL (1) PL320610A1 (fr)
TR (1) TR199501542A2 (fr)
WO (1) WO1996017874A1 (fr)
ZA (1) ZA9510195B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (fr) 1997-07-25 1999-01-27 Institut Gustave Roussy Utilisation de ligands de MHC classe II (CD4 et LAG-3) comme adjuvants pour la vaccination de LAG-3 dans le traitement du cancer
AU5588099A (en) * 1998-08-28 2000-03-21 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
EP1156060B1 (fr) * 2000-05-12 2007-06-27 GPC Biotech AG Peptides/protéines humaines causant ou menant à la mort de cellules y compris de cellules lymphoides tumorales
EP1156062A1 (fr) * 2000-05-12 2001-11-21 GPC Biotech AG Peptides/protéines immunomodulants et liants à un antigène du CMH classe II humain
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
US6894149B2 (en) 2001-10-11 2005-05-17 Protein Design Labs, Inc. Anti-HLA-DA antibodies and the methods of using thereof
US7262278B2 (en) 2001-10-15 2007-08-28 Kirin Beer Kabushiki Kaisha Anti-HLA-DR antibody
WO2006115509A2 (fr) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
CA2794499A1 (fr) * 2010-04-01 2011-10-06 Immumomedics, Inc. Utilisation d'anticorps pour reduire le nombre de cellules contenant des antigenes et de cellules dendritiques
KR102647825B1 (ko) * 2021-07-22 2024-03-14 서울대학교산학협력단 항-hla-dp 단클론 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068790B1 (fr) * 1981-06-25 1986-02-26 The Board Of Trustees Of The Leland Stanford Junior University Méthode immunothérapeutique allèle spécifique et forme de dosage
DE69028713T3 (de) * 1989-12-27 2004-05-13 Centocor, Inc. Schimäre immunoglobuline für cd4-rezeptoren
ES2196002T3 (es) * 1991-07-25 2003-12-16 Idec Pharma Corp Anticuerpos recombinantes para terapia humana.

Also Published As

Publication number Publication date
BR9509902A (pt) 1997-10-21
AR002005A1 (es) 1998-01-07
AU4256096A (en) 1996-06-26
JP2001506122A (ja) 2001-05-15
CA2206471A1 (fr) 1996-06-13
TR199501542A2 (tr) 1996-07-21
PL320610A1 (en) 1997-10-13
EP0787151A1 (fr) 1997-08-06
CN1168679A (zh) 1997-12-24
IL116228A0 (en) 1996-03-31
FI972430A7 (fi) 1997-06-06
FI972430A0 (fi) 1997-06-06
NO972522D0 (no) 1997-06-03
ZA9510195B (en) 1996-06-07
WO1996017874A1 (fr) 1996-06-13
CZ172497A3 (en) 1997-10-15
MX9704225A (es) 1997-09-30
HUT77342A (hu) 1998-03-30
FI972430L (fi) 1997-06-06
PE52996A1 (es) 1996-12-12
MA23739A1 (fr) 1996-07-01
CO4480041A1 (es) 1997-07-09

Similar Documents

Publication Publication Date Title
DE69429095D1 (de) Humanisierte antikoerper
WO1998057994A3 (fr) Anticorps opsoniques, monoclonaux protecteurs, et chimeres specifiques a l'acide lipoteichoique des bacteries gram positif
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
DK0673418T3 (da) Monoklonale antistoffer rettet mod mikrotubulusassocieret tau-protein, hybridomaer, der secernerer disse antistoffer, antig
ATE263189T1 (de) Antikörper gegen menschliches prostatspezifisches drüsenkallikrein
BR9713521A (fr)
EP0677533A3 (fr) Anticorps contre des épitopes homologues aus auto-antigènes, méthode de préparation et applications
AU628948B2 (en) Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
DK0969873T3 (da) Multiple carbonhydratholdige glycopeptid-antigener, vaccine indeholdende dem og anvendelse deraf
DK0845998T3 (da) Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles
AU2002223462A1 (en) Use of cd28-specific monoclonal antibodies for stimulating blood cells that lackcd28
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
CA2137638A1 (fr) Anticoprs monoclonaux antigangliosides et leur emploi dans l'immunotherapie active specifique a des tumeurs malignes
GR3029483T3 (en) Antibodies against t-cells as therapeutics
CA2036814A1 (fr) Anticorps monoclonaux contre les antigenes associes aux tumeurs, mode de preparation et d'utilisation
ATE169680T1 (de) 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper
PL314414A1 (en) Antiidiotypic antibodies capable to induce an immunological response in respect to the receptor of epidermis growth factor
NO962827L (no) Monoklonale antistoffer mot antigener uttrykt av hematopoietider facilitatoriske celler
BR9702101A (pt) Hibridoma e anticorpo monoclonal
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
ATE209041T1 (de) Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendung
ECSP951605A (es) Fragmentos de anticuerpos monoclonales que tienen actividad inmunosupresora, case ran 4105/171
EP0450573A3 (fr) Anticorps pour le traitement et le diagnostic d'infections de Pseudomonas aeruginosa
刘亚霞 et al. ISOLATION AND STUDY OF THE CD2 ANTIGEN PURIFIED BY AFFINITY CHROMATOGRAPHY WITH OKT11-LIKE MAB
CA2165672A1 (fr) Anticorps specifiques pour la kallikreine glandulaire de la prostate de l'homme